A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)
Study Identifier
M25-207
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
Phase 1
Sex
Female & Male
Age
18+ years
Protocol Summary
The objective of this Phase 1 study is to assess the safety and efficacy of single treatment of AGN-151586 and of OnabotulinumtoxinA in the glabellar complex of participants with moderate to severe glabellar lines (GL).
Study Locations
Location
Status
Location
Investigate MD /ID# 270771
Scottsdale, Arizona, United States, 85260
Status
Not applicable
Location
Eye Research Foundation /ID# 270827
Newport Beach, California, United States, 92663
Status
Not applicable
Location
Marcus Facial Plastic Surgery /ID# 270770
Redondo Beach, California, United States, 90277
Status
Not applicable
Location
Skin Research Institute LLC /ID# 270831
Coral Gables, Florida, United States, 33146-1837
Status
Not applicable
Location
Skincare Physicians /ID# 271018
Chestnut Hill, Massachusetts, United States, 02467
Status
Not applicable
Location
Wilmington Dermatology Center /ID# 270828
Wilmington, North Carolina, United States, 28403
Status
Not applicable
Showing {first} - {last} of {total} Results